Peri-Transfusion QOL Assessments (PTQA): A New Paradigm of Transfusion Decision Support for Patients With MDS
- Status
- COMPLETED
- Phase
- NA
Clinical Trials Related to Myelodysplastic Syndromes
Related studies linked through entity extraction aliases.
Study of the Outcome of Patients With Acute Myeloblastic Leukemia and Myelodysplastic Syndrome Receiving Iron Chelation Therapy After Allogeneic Hematopoietic Stem Cell Transplantation
- Status
- UNKNOWN
- Phase
- N/A
HLA 10/10 Matched Unrelated Donor vs Haploidentical Allogenic Hematopoietic Stem Cell Transplantation
- Status
- UNKNOWN
- Phase
- PHASE3
Impact of 2 Transfusion Strategies on Quality of Life of Multitransfused Patients With Low-risk Myelodysplastic Syndrome
- Status
- TERMINATED
- Phase
- NA
Immunophenotyping of Blood Cells in the Diagnosis Work-up of Myelodysplastic Syndromes
- Status
- RECRUITING
- Phase
- N/A
EPITHINK: Epigenetic Drug Treatment and Therapeutic Immunotherapy With NKR-2
- Status
- WITHDRAWN
- Phase
- PHASE1
Biological Predictive Factors of Response to ESA in Low Risk MDS Patients
- Status
- COMPLETED
- Phase
- PHASE4
COaching and Prehabilitation: Faisability Study in Patients With Acute Myeloid Leukemia and Myelodysplastic Syndrome
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- NA
Efficiency of Antibacterial Prophylaxis in Azacitidine Treated Patients
- Status
- COMPLETED
- Phase
- PHASE3
Nivolumab and Tocilizumab for Relapsed Hematological Malignancy Post-allogeneic Transplant
- Status
- TERMINATED
- Phase
- PHASE1
Alpha/Beta TCD HCT in Patients With Inherited BMF Disorders
- Status
- RECRUITING
- Phase
- PHASE2
A Study of JNJ-64619178, an Inhibitor of PRMT5 in Participants With Advanced Solid Tumors, NHL, and Lower Risk MDS
- Status
- COMPLETED
- Phase
- PHASE1
CPX-351 (Vyxeos™) for Transplant Eligible, Higher Risk Patients With Myelodysplastic Syndrome
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
A Pilot Trial of Atorvastatin in Tumor Protein 53 (p53) -Mutant and p53 Wild-Type Malignancies
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Study of Quality of Life in Older vs. Younger Adult Patients Undergoing Allogeneic Hematopoietic Cell Transplantation for Myelodysplastic Syndromes
- Status
- COMPLETED
- Phase
- N/A
A Trial to Evaluate the Potential Impact of Renal Impairment on the Pharmacokinetics and Safety of CPX-351
- Status
- COMPLETED
- Phase
- PHASE1
Expanded/Activated Gamma Delta T-cell Infusion Following Hematopoietic Stem Cell Transplantation and Post-transplant Cyclophosphamide
- Status
- RECRUITING
- Phase
- PHASE1
Ascorbic Acid Levels in MDS, AML, and CMML Patients
- Status
- COMPLETED
- Phase
- N/A
IDH1 (AG 120) Inhibitor in Patients With IDH1 Mutated Myelodysplastic Syndrome
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Phase 1-2 Study of Low Dose ASTX727 (ASTX727 LD) in Lower Risk MDS
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2